fbpx

Hoya Invests in Medical Devices

Hoya Vision Care Canada logo

HOYA has announced an investment in Salutaris Medical Devices, Inc., a company specializing in medical devices for treatment of wet age-related macular degeneration (AMD).

Salutaris MD develops experimental hand-held instruments to treat AMD by precisely targeting lesions with radiation. Radiation therapy suppresses the growth of faulty blood vessels and reduces inflammation and scarring.

“The currently available treatment regimens for wet AMD are costly, burdensome and there is a large unmet need for more effective therapies. We are excited about our partnership with HOYA that will further enable our commercialization efforts,” said Dr. Laurence Marsteller, CEO of Salutaris MD.

The specific terms of the agreement were not disclosed.

Further Information: http://www.hoya.co.jp/english/company/news/20150326.html

Overnight contact lens wearing slows myopia in children

Orthokeratology may be effective at slowing the progression of myopia in children, according to the results of a meta-analysis published in Optometry and Vision Science.

Orthokeratology (ortho-K), the wearing of custom rigid contact lenses at night, is believed to control myopia in children by shaping the growth of the eye.

The results, gathered from seven separate studies, included data on 435 myopic children between the ages of six and sixteen. The studies measured the increase in axial length over time. After a two-year period it was found that the average difference in axial growth between the group of children receiving the ortho-K treatment and the group without was a quarter of a millimetre.

Despite the findings, the Canadian Ophthalmological Society does not endorse the use of ortho-K due to the risk of contracting microbial keratitis associated with the overnight wearing of rigid contact lenses.

For more information: http://www.cos-sco.ca/advocacy-news/position-policy-statements/orthokeratology-myopia/

Transitions® Signature Graphite Green Lenses Among Selected Products of the Year in Canada

Transitions® SignatureTM graphite green lenses by Essilor were voted Product of the Year in the eye care category by Canadian consumers.

This honour is part of the program from Rogers Publishing Limited. The finalists were chosen by a jury panel made up of product experts, academics and media personalities. The selected products were then presented to consumer respondents and rated on four criteria: product satisfaction, product innovation, product appeal and intent to purchase. A total of 33 Canadian products were named products of the year.

“According to our research, innovation is an important factor for Canadians in choosing products,” said Rosemary Munroe, the director of Rogers Media and Product of the Year. “This year’s winners are not only innovative, they are convenient and easy to use. Consumers are faced with so many choices when they shop, and the Product of the Year seal helps them make decisions and leads them to quality products they can trust.”

Quality Checklist Now Added to all HOYA Canada Edge & Assembly Jobs

HOYA Canada, effective March 26, will include a quality checklist with every pair of edged and assembled glasses as a mark of care the company takes with each job completed, according to a statement from HOYA Canada President, Ahmos Henry. The checklist includes an “inspected by” location for the HOYA technicians to sign-off, affirming the individuals quality approval of the outgoing job.

Peter Lothes Head of Satisloh North America

Peter Lothes is the new president of Satisloh North America.

Lothes will be responsible for sales and operations for Satisloh in Canada and the U.S. He is replacing Larry Clarke, who was appointed president and COO of Satisloh AG last fall and relocated to Switzerland.

A graduate of Ashland University, in Ohio, Lothes was president of his family’s business, Select Optical, for over 17 years. The Columbus laboratory was acquired by Essilor of America in 2004. Five years later, Lothes became vice-president of operations–partner labs at Essilor of America, a position he held until recently. He was responsible for Essilor’s five largest production labs in the U.S. and Mexico.

Click HERE to read more.

Featured Posts

Managing anxious children optometry pre-testing

Pivot to Patience: Managing the Emotionally Elevated Child in Pre-Testing

Discover 5 EQ-based strategies for managing an anxious or emotionally elevated child during optometry pre-testing in 2026. Learn how to de-escalate and ensure accurate clinical data.

Learn More
Voila July-August Optik 2026 Centennial DILLI DALLI 7111

Dilli Dalli – Now Available in Canda

Now available in Canada, Dilli Dalli offers fit-focused eyewear for infants, toddlers and children, with SoftTouch, TR-90 and lightweight metal options designed to support pediatric dispensing.

Read more
AYA Optical logo and Carla DAngelo photo 2026

AYA Optical: Where Art Meets Eyewear

AYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.

Read more
The Vision Council Foundation logo

The Vision Council Foundation Expands “See What Matters” with New Back‑to‑School Eye Health Toolkit

The Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.

Read more
Bausch + Lomb

Bausch + Lomb Advances Two First‑in‑Class Eye Health Therapies Following New Clinical Results

Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.

Read more
Managing anxious children optometry pre-testing

Pivot to Patience: Managing the Emotionally Elevated Child in Pre-Testing

Discover 5 EQ-based strategies for managing an anxious or emotionally elevated child during optometry pre-testing in 2026. Learn how to de-escalate and ensure accurate clinical data.

Learn More
Voila July-August Optik 2026 Centennial DILLI DALLI 7111

Dilli Dalli – Now Available in Canda

Now available in Canada, Dilli Dalli offers fit-focused eyewear for infants, toddlers and children, with SoftTouch, TR-90 and lightweight metal options designed to support pediatric dispensing.

Read More
AYA Optical logo and Carla DAngelo photo 2026

AYA Optical: Where Art Meets Eyewear

AYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.

Read More
The Vision Council Foundation logo

The Vision Council Foundation Expands “See What Matters” with New Back‑to‑School Eye Health Toolkit

The Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.

Read More
Bausch + Lomb

Bausch + Lomb Advances Two First‑in‑Class Eye Health Therapies Following New Clinical Results

Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.

Read More
Managing anxious children optometry pre-testing

Pivot to Patience: Managing the Emotionally Elevated Child in Pre-Testing

Discover 5 EQ-based strategies for managing an anxious or emotionally elevated child during optometry pre-testing in 2026. Learn how to de-escalate and ensure accurate clinical data.

Learn More
Voila July-August Optik 2026 Centennial DILLI DALLI 7111

Dilli Dalli – Now Available in Canda

Now available in Canada, Dilli Dalli offers fit-focused eyewear for infants, toddlers and children, with SoftTouch, TR-90 and lightweight metal options designed to support pediatric dispensing.

Read more
AYA Optical logo and Carla DAngelo photo 2026

AYA Optical: Where Art Meets Eyewear

AYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.

Read more
The Vision Council Foundation logo

The Vision Council Foundation Expands “See What Matters” with New Back‑to‑School Eye Health Toolkit

The Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.

Read more
Bausch + Lomb

Bausch + Lomb Advances Two First‑in‑Class Eye Health Therapies Following New Clinical Results

Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.

Read more
Managing anxious children optometry pre-testing

Pivot to Patience: Managing the Emotionally Elevated Child in Pre-Testing

Discover 5 EQ-based strategies for managing an anxious or emotionally elevated child during optometry pre-testing in 2026. Learn how to de-escalate and ensure accurate clinical data.

Learn More
Voila July-August Optik 2026 Centennial DILLI DALLI 7111

Dilli Dalli – Now Available in Canda

Now available in Canada, Dilli Dalli offers fit-focused eyewear for infants, toddlers and children, with SoftTouch, TR-90 and lightweight metal options designed to support pediatric dispensing.

Read more
AYA Optical logo and Carla DAngelo photo 2026

AYA Optical: Where Art Meets Eyewear

AYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.

Read more
The Vision Council Foundation logo

The Vision Council Foundation Expands “See What Matters” with New Back‑to‑School Eye Health Toolkit

The Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.

Read more
Bausch + Lomb

Bausch + Lomb Advances Two First‑in‑Class Eye Health Therapies Following New Clinical Results

Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.

Read more